[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578556":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":40,"responsibleParty":57,"collaborators":26,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":26,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":26,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":81,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Madigan Army Medical Center","FED",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Arm","PLACEBO_COMPARATOR","This arm will receive the placebo pill",[13],"Drug: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Experimental Arm","EXPERIMENTAL","This arm will receive simethicone",[19],"Drug: Simethicone 80 MG",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Simethicone 80 MG","Patients will receive simethicone 80mg four times per day for 2 weeks post-operatively.",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo","Patients in the control group will receive a placebo pill four times per day for 2 weeks",[9],[32,37],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Brooklyn Williams, DO","CONTACT","(253) 968-3105","brooklyn.c.williams3.mil@health.mil",{"name":38,"role":34,"phone":35,"phoneExt":26,"email":39},"Christopher Porta, MD","christopher.r.porta.civ@health.mil",[41],{"facility":5,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Tacoma","Washington","98431","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-122.44429,47.25288,{"lat":52,"lon":51},[55],{"name":38,"role":34,"phone":56,"phoneExt":26,"email":39},"253-968-3105",{"type":58,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100578556","phase-4-simethicone-as-part-of-eras-in-bariatric-surgery-patients-100578556",false,"NCT06812832","Simethicone as Part of ERAS in Bariatric Surgery Patients","Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol","Inclusion Criteria:\n\n* Foregut procedures\n\nExclusion Criteria:\n\n* Non-foregut procedures\n* Allergy to simethicone\n* Pregnancy or breastfeeding\n* Minors under 18 years of age",true,"ALL","18 Years","89 Years",{"count":71,"type":72},260,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery.\n\nThe purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.",[78,79,80],"Simethicone","Bariatric Surgery","Post-operative Pain",[78,82,83,84],"Gas-X","Foregut","Post-operative pain","2025-06-11",{"date":87,"type":88},"2025-06-15","ACTUAL",{"date":90,"type":88},"2025-04-08",{"date":92,"type":72},"2029-03",{"name":5,"class":6},1]